	Therapy-induced microenvironmental senescence in tumor treatment resistance: From mechanism to therapy. Drug Resist Updat Wei R, Liu D, Shu K, Zhu H. PMID: 42447534 [PubMed - as supplied by publisher]
	Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study. Eur J Cancer Broekman THT, Mackay TM, de Vos-Geelen J, Cirkel GA, Graus MUJE, de Groot JB, Homs MYV, Luelmo SAC, Mekenkamp LJM, Streppel MM, Voermans RP, Wumkes ML, Besselink MG, van der Geest LG, Wilmink JW, Dutch Pancreatic Cancer Group. PMID: 42447514 [PubMed - as supplied by publisher]
	Cannabis use and testicular germ cell tumour subtypes in the french nationwide TESTIS case-control study. Eur J Cancer Coste A, Hosseini B, Praud D, Amadou A, Perrin J, Charbotel B, Schüz J, Fervers B, TESTIS study group. PMID: 42447513 [PubMed - as supplied by publisher]
	Vitiligo and skin cancer risk across racial/ethnic groups: A retrospective propensity score-matched study on 123,179 patients. Eur J Cancer Nazzal Y, Najeeb M, Dagher J, Bertolini M, Passeron T, Ludwig RJ, Curman P. PMID: 42447511 [PubMed - as supplied by publisher]
	Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study. Cancer Res Commun Felip E, Kuo P, Garrido P, Chouaid C, Mountzios G, Tiseo M, Daniel DB, Zavodovskaya M, Tang S, Su-Feher L, Patel R, Park JK, Jürgensmeier JM, Summers Y. PMID: 42447505 [PubMed - as supplied by publisher]
	[Merkel cell carcinoma: current surgical approaches and multidisciplinary treatment]. Rev Med Inst Mex Seguro Soc Romero-López A, Herrera-Ramírez A, Pérez-Esparza G, Juárez-Carrera AL, Cruz-Vargas JF. PMID: 42447476 [PubMed - in process]
	Feasibility, Usability, and Preliminary Effectiveness of an mHealth App to Promote Screening Behaviors Among High-Risk Populations for Breast Cancer: Randomized Controlled Pilot Study. JMIR Mhealth Uhealth Zhang L, Xu M, Zhang X, Li X, Wang S, Zhou F, Han J. PMID: 42447462 [PubMed - in process]
	Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial. J Clin Oncol Srour SA, Chahoud J, Drakaki A, Curti BD, Gibney GT, Tang L, Jiang Y, Charmsaz S, Robbins PB, McLeroy J, Severyn CJ, Le Gall JB, Roberts ZJ, Tannir NM, Pal S, Kotecha RR. PMID: 42447427 [PubMed - as supplied by publisher]
	Survival and Economic Benefits of Implementing Evidence-Based Tobacco Treatment Across US Cancer Care. JCO Oncol Pract Kypriotakis G, Versace F, Karam-Hage M, Minnix JA, Blalock J, Beneventi D, Cui Y, Cinciripini PM, Robinson JD, Shih YT, Warren GW. PMID: 42447426 [PubMed - as supplied by publisher]
	Efficacy evaluation of novel targeted drugs in patients with human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis based on multiple sets of clinical data. J Int Med Res Lan Y, Wang R, Liu S. PMID: 42447291 [PubMed - in process]
	Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy. ACS Appl Mater Interfaces Tan BSN, Zhao Y. PMID: 42447222 [PubMed - as supplied by publisher]
	Decision tree model to predict one-year survival in ambulatory patients with advanced cancer. PLoS One Hiratsuka Y, Yoon SJ, Suh SY, Kim YJ. PMID: 42447165 [PubMed - indexed for MEDLINE]
	Deep convolutional GAN and hypernet-based neural architecture search for brain tumor diagnosis detection and classification. PLoS One Swathi S, Rajalakshmi M. PMID: 42447150 [PubMed - indexed for MEDLINE]
	The clinical dilemma of vanishing lesions after systemic therapy in oligometastatic esophagogastric cancer: a narrative review. Dig Surg Bronzwaer SFC, Haarlem IV, Kroese TE, van Laarhoven HWM, Ruurda JP, van Hillegersberg R, van Rossum PSN. PMID: 42447136 [PubMed - as supplied by publisher]
	Clinicopathological Characteristics and Survival in Young Adults With Oral Squamous Cell Carcinoma: AÂ Retrospective Comparative Cohort Study. Oral Dis Eitner-Pchalek JC, Wagner C, Linz C, Kreppel M. PMID: 42447131 [PubMed - as supplied by publisher]
	Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy. PLoS One Frisch A, Kahn J, Collettini F, Steinhagen P, Fehrenbach U, Gebauer B, Amthauer H, Schatka I, Herzler P, Wieners G, Lüdemann WM. PMID: 42447129 [PubMed - indexed for MEDLINE]
	Mitochondrial Gene Expression-based Model for the Prediction of Thyroid Cancer Prognosis. Endocr Connect Zha W, Li J, Li Y, Li H, Yang X, Liu Y, Wang C, Xu Y, Li X, Wang X, Liu G. PMID: 42447036 [PubMed - as supplied by publisher]
	Free-Structure based Efficient NIR-II FMT: A Solution for Human Hepatocellular Carcinoma Detection. IEEE Trans Biomed Eng Pei Z, Du Y, Li C, Shi X, Guo H, Tian J, Hu Z. PMID: 42447015 [PubMed - as supplied by publisher]
	Efficacy and safety of dexamethasone and prednisone for therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Clin Invest Med Lv W, Li D, Li J, Xie Y, Yang X. PMID: 42446908 [PubMed - indexed for MEDLINE]
	Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk. JAMA Netw Open Nguyen CM, Skaar TC, Imperiale TF, Johnson TS, Monahan PO, Turk AA, Nguyen MP. PMID: 42446881 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1955062

Page 1 of 97754



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy